Janssen

• J&J expects COVID-19 vaccine sales boost in 2022 on strong demand

  Johnson & Johnson is expecting that sales of its COVID-19 vaccines could rise to $3.5 billion in 2022, though the total will not account for much of its overall profits.

  Economy

  Jan 25, 2022
  
• Middlesex London Health Unit extends eligibility for COVID-19 booster shots

  This comes after the Ontario government announced Wednesday that it was extending eligibility for booster doses of a COVID-19 vaccine.

  Health

  Nov 3, 2021
  
• Advertisement
• Johnson & Johnson eyes US$2.5B in COVID-19 vaccine sales despite Q3 slide

  Johnson & Johnson said it recorded US$766 million in sales of the shot in the first nine months of 2021, and would need sales to triple in the fourth quarter to meet its target.

  Money

  Oct 19, 2021
• Advertisement
• Kelowna events raise funds and awareness for prostate cancer

  'The goal is to bring awareness for prostate cancer. It's one of the most commonly diagnosed cancers there are,' said Doug Sutherland, a backer of the Plaid for Dad campaign.

  Health

  Jun 18, 2021
• Health Canada updates label on Johnson & Johnson vaccine, but says benefits outweigh risk

  The move comes just days after U.S. health officials lifted a 10-day pause on the vaccine after a handful of people suffered rare blood clotting after having received a dose.

  Canada

  Apr 26, 2021
• AstraZeneca’s 1.5M COVID-19 shots from Baltimore plant are safe: Health Canada

  "Canadians can be assured that Health Canada is taking all necessary steps to ensure that any products coming from this facility will only be used if they are safe and effective."

  Canada

  Apr 25, 2021
• Johnson & Johnson’s vaccine won’t be the ‘workhorse’ in Canada’s rollout

  "Are we going to up our ante and ensure that we are — and we can be — global leaders in the production of those kinds of vaccines in this country?"

  Health

  Mar 30, 2021
• Janssen to begin final stage trials of coronavirus candidate in the U.K.

  The Jannsen vaccine is among the six experimental coronavirus vaccines that Britain has ordered as part of a planned 350 million-dose stockpile.

  Health

  Nov 16, 2020